The WHO Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations outline a public health response for five key populations (men who have sex with men, trans and gender diverse people, sex workers, people who inject drugs and people in prisons and other closed settings). They present and discuss new recommendations and consolidate a range of recommendations and guidance from current WHO guidelines.
Resources
Medical professional
Around 216,000 people in the UK are living with hepatitis C so it is important that all medical professionals have access to the latest training, information and advice on hepatitis C management. Find here links to relevant materials for clinicians, nurses, GPs, prison healthcare staff and other medical professionals.
Showing 31 to 40 of 418 resources
-
Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations
UK, Rest of World 01 Aug 2022 Reports & Research, Strategy & Planning PDF -
Webinar summary: three years to go - where are we in the journey to elimination? May 2022
Held in May 2022 – only three years from the 2025 NHS England target to eliminate hepatitis C as a significant public health concern – this webinar of the HCV Action network aimed to share information about the latest data on hepatitis C, what we can observe about trends from what we already have and what types of further data collection we need to fill gaps in our current knowledge and guide efforts towards elimination.England Reports & Research, Strategy & Planning PDF -
Good practice case study: The Cocoon project
The Cocoon project, set up in Tayside, Scotland seeks to address the high rate of drug-related deaths in the area. The project delivers point-of-care diagnosis of HCV in needle exchange sites, while also integrating services which typically require travel to alternate NHS sites to reduce the burden of multiple visits and different providers. The result is a ‘one-stop’ holistic care bundle which seeks to address the inequity of access experienced by PWUD by increasing their engagement through services tailored to their specific needs.Scotland 31 May 2022 Case study PDF -
Webinar recording: three years to go - where are we in the journey to hepatitis C elimination?With only three years to go to NHS England's 2025 elimination target, the aim of this HCV Action webinar was to share information about the latest data on hepatitis C, what we can observe about trends from what we already have, and what types of further data collection we need to fill gaps in our current knowledge and guide efforts. It included speakers from NHS England, the UK Health Security Agency, The Hepatitis C Trust, and Hep C U Later.England 16 May 2022 Training, Reports & Research Video
-
Needle Exchange Surveillance Initiative: Prevalence of blood-borne viruses and injecting risk behaviours among people who inject drugs attending injecting equipment provision services in Scotland, 2008 to 2020
The Needle Exchange Surveillance Initiative (NESI) has published its latest report using survey data to measure and monitor the prevalence of blood-borne viruses – hepatitis C virus and HIV – and injecting risk behaviours among people who inject drugs (PWID) in Scotland.
The report uses data from Scotland level and NHS board level surveys, and provides information to evaluate and better target interventions aimed at reducing the spread of infection amongst PWID.
Some key findings of the report include:
Scotland Reports & Research PDF -
Reframing Reinfection: towards sustained hepatitis C elimination in the UK
A joint effort by HCV Action and The Hepatitis C Trust, this report sets out to understand what the NHS and frontline services who work with people at risk of hepatitis C are seeing in relation to reinfection, what is already being done, and what more we might put in place locally and nationally to address the problem.UK 31 Mar 2022 Reports & Research PDF -
Hepatitis C in England 2022: full report
The 2022 Hepatitis C in England report from the UK Health Security Agency reports that deaths from hepatitis C fell by 35% between 2015 and 2020. The data shows the estimated prevalence of chronic hepatitis C in England has continued to decline to around 81,000 in 2020 (compared to 129,000 in 2015) – a 37% fall in the general population. Provisional data suggests that there has been a 40% decline in people who inject drugs.England 03 Mar 2022 Reports & Research PDF -
Hepatitis C in England 2022: short report
This resource is a shorter version of the full Hepatitis C in England 2022 report from the UK Health Security Agency. The report details that deaths from hepatitis C fell by 35% between 2015 and 2020. The data shows the estimated prevalence of chronic hepatitis C in England has continued to decline to around 81,000 in 2020 (compared to 129,000 in 2015) – a 37% fall in the general population. Provisional data suggests that there has been a 40% decline in people who inject drugs.England 03 Mar 2022 Reports & Research PDF -
Hepatitis C in England 2022: Infographics
These infographics from the UK Health Security Agency provide a visual representation of the data from the Hepatitis C in England 2022 report.England 03 Mar 2022 Reports & Research PDF -
Webinar summary: Hepatitis C services in Wales, January 2022
The HCV Action webinar on Hepatitis C services in Wales took place in January 2022, and addressed the current status of hepatitis C services in Wales. Bringing together professionals from University Hospital Wales, Cardiff and Vale University Health Board, The Hepatitis C Trust and the Welsh Government, the webinar explored a range of issues in Wales’ journey to elimination. This resource offers an overview of all presentations .Wales 14 Feb 2022 Reports & Research, Strategy & Planning PDF